Home › Entities › general › EpiVacCorona

EpiVacCorona

experimental Russian COVID-19 vaccine
Thing general Q98947046
Press Enter · cited answer in seconds

EpiVacCorona

Summary

EpiVacCorona has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.[1]

Key Facts

  • EpiVacCorona's developer is recorded as State Research Center of Virology and Biotechnology VECTOR[2].
  • EpiVacCorona is a type of COVID-19 vaccine[3].
  • EpiVacCorona is a type of protein subunit vaccine[4].
  • EpiVacCorona is a type of vaccine candidate[5].
  • EpiVacCorona's Commons category is recorded as EpiVacCorona[6].
  • EpiVacCorona's country of origin is recorded as Russia[7].
  • EpiVacCorona's route of administration is recorded as intramuscular injection[8].
  • EpiVacCorona's route of administration is recorded as deltoid muscle[9].
  • EpiVacCorona's route of administration is recorded as quadriceps femoris muscle[10].
  • EpiVacCorona's described by source is recorded as Simple, Blind, Placebo-controlled, Randomized Study of the Safety, Reactogenicity and Immunogenicity of Vaccine Based on Peptide Antigens for the Prevention of COVID-19 (EpiVacCorona), in Volunteers Aged 18-60 Years (I-II Phase)[11].
  • EpiVacCorona's vaccine for is recorded as COVID-19[12].

Body

Definition and Type

Recorded subclass of include COVID-19 vaccine[3], protein subunit vaccine[4], and vaccine candidate[5].

Why It Matters

EpiVacCorona has Wikipedia articles in 14 language editions, a strong signal of global cultural recognition.[1]

Related Entities

Russia State Research Center of Virology and Biotechnology VECTOR

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.
  11. [12] ↑ . covid-19tracker.milkeninstitute.org. Retrieved . covid-19tracker.milkeninstitute.org. Provenance: wikidata.org.

Aggregate / graph-position facts

  1. [1] ↑ . Wikidata sitelinks. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). EpiVacCorona. Retrieved April 10, 2026, from https://4ort.xyz/entity/epivaccorona
MLA “EpiVacCorona.” 4ort.xyz Knowledge Graph, 4ort.xyz, 10 Apr. 2026, https://4ort.xyz/entity/epivaccorona.
BibTeX @misc{4ortxyz_epivaccorona_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{EpiVacCorona}}, year = {2026}, url = {https://4ort.xyz/entity/epivaccorona}, note = {Accessed: 2026-04-10}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): EpiVacCorona — https://4ort.xyz/entity/epivaccorona (retrieved 2026-04-10)

Canonical URL: https://4ort.xyz/entity/epivaccorona · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 24d ago · Mitte27 · 2026-06-26 view diff on Wikidata ↗
    Instance of → Q12140
    Developer → —
    Subclass of → COVID-19 vaccine, protein subunit vaccine, vaccine candidate
    Aliases → —
    + 7 other properties edited (see Wikidata diff for full list)
    "/* wbcreateclaim-create:1| */ [[Property:P31]]: [[Q12140]], #quickstatements; #temporary_batch_1782435809839"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.